Elisabeth I Minder

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Prognostic Factors

Ejection Fraction

Top Venues

Therapeutic advances in rare disease

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Anna-Elisabeth Minder, Louisa G Kluijver, Jasmin Barman-Aksözen, Elisabeth I Minder, Janneke G Langendonk
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management. Liver international : official journal of the International Association for the Study of the Liver (2024)
Anna-Elisabeth Minder, Jasmin Barman-Aksoezen, Mathias Schmid, Elisabeth I Minder, Henryk Zulewski, Christoph E Minder, Xiaoye Schneider-Yin
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study. Therapeutic advances in rare disease 2 (2021)
Anna-Elisabeth Minder, Jasmin Barman-Aksoezen, Mathias Schmid, Elisabeth I Minder, Henryk Zulewski, Christoph E Minder, Xiaoye Schneider-Yin
Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study. Therapeutic advances in rare disease 2 (2021)
Elisabeth I Minder, Jasmin Barman-Aksözen
Iron and erythropoietic porphyrias. Blood 126 (2) (2015)